20 May 2013
Keywords: Mylan, Teva, Provigil, Litigation, USA, Narcolepsy, Sleep apnea
Article | 10 June 2012
US generic major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Pharmaceuticals has resolved all disputes with Teva Pharmaceuticals USA, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 June 2012
11 June 2012
17 May 2013
© 2013 thepharmaletter.com